A significant number of patients was enrolled in the DC-based immunotherapy trial. After vaccination, vaccine-induced depigmentation and vitiligo were observed.
Immune monitoring of DC vaccinated advanced melanoma patients
Clinical trials of DC-based immmunotherapy of melanoma patients